Class [16]
Paper Goods and Printed Material
Paper and printed articles, namely, newsletters and magazines, books, printed publications, printed reports, printed instructional and teaching materials, all in the field of biological material and substances and medical devices testing and analysis, and in the fields of virology and biosafety testing and analysis
Class [42]
Computer & Software Services & Scientific Services
Biological, material and substance and medical devices testing, analysis, research and study services; biochemistry services for use in the field of biological material and substances and medical devices testing and analysis; industrial design services; conducting and creating project studies for use in the field of biological, material and substances and medical devices testing and analysis; biological, material and substance structural characterization services in the field of biological material and substances and medical devices testing and analysis; production monitoring in the field of biological material and substances and medical devices testing and analysis; environmental surveys; pre-clinical, clinical and production cell bank, virus seed and batch release services; testing of monoclonal antibodies, proteins and recombinant proteins, virus and bacterial vaccines and cell therapies, gene therapy vectors and other biopharmaceutical products intended for human and veterinary administration; quality control of biological manufacturing testing services; virology services; viral clearance chromatography services; cell culture based assays and services; in vitro adventitious virus assays and retrovirus assays and services; cell line characterization services (including without limitation, validation and development of assays and methods and characterization of cell banks or batches or product derived from cell lines, of human or animal origin); detection of viruses derived from animal products assays and services; screening virus vectors/vaccines for the presence of infectious contaminants assays and services; services in the field of molecular biology, including validation and development of assays and testing services; Quantitative Polymerase Chain Reaction (qPCR) testing services for both preclinical and clinical requirements; species-specific virus detection services by qPCR including but not restricted to human, simian, insect, murine, avian, chicken, duck, equine, bovine and porcine viruses; patient monitoring and biodistribution study services; identity, purity and stability assays and testing services, including microbial identity and genetic stability of cell lines; isoenzyme assay and DNA fingerprinting services; electron microscopy services, including without limitation, transmission electron microscopy and virus particle detection and quantification; microbiology services including sterility, mycoplasma and mycobacteria culture-based assays and testing services; biosafety services; consultancy services and preparation of reports in connection with the aforesaid services.
